The UK’s Competition Appeal Tribunal has upheld the Competition and Markets Authority (CMA) decision that GlaxoSmithKline and some generic suppliers of the anti-depressant paroxetine broke competition law. The Competition Appeal Tribunal (Tribunal) has, however, imposed reduced fines of £27.1 million (US$38.26 million) on the firms involved.
Paroxetine is relied on by patients to relieve symptoms of depression. GlaxoSmithKline had agreed to make payments totalling £50 million (US$70.59 million) to other generic suppliers of paroxetine, including Generics Limited and Alpharma Limited, in settlement of patent litigation.
In a decision issued in 2016, the CMA found that these payments were aimed at delaying the potential entry of these competitors supplying generic medicines into the UK market and were unlawful. The CMA imposed fines totalling £44.99 million (US$63.52 million) on the companies directly involved in the infringements – and, where relevant, on their parent companies or successors to these companies.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
FCC Votes to Restore Net Neutrality Rules
Apr 25, 2024 by
nhoch@pymnts.com
Apple Rejects Spotify’s Updated App Over In-App Pricing Disclosure
Apr 25, 2024 by
CPI
FCC Set to Reinstate Net Neutrality Rules Today
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI